now known to be at least four adenosine receptor subtypes, denoted A 1 , A 2a , A 2b , and A 3 . The most Background. Many effects of adenosine on renal function have been identified. The development of adenos-frequently examined effects of adenosine on the kidney, including constriction of the afferent arteriole and ine receptor blockers has made it possible to identify which of these effects are exerted by endogenous aden-mesangial cell contraction, suppression of renin release, stimulation of proximal tubule cell phosphate uptake, osine. At least four adenosine receptor subtypes, denoted A 1 , A 2a , A 2b , and A 3 are currently known. In and inhibition of thick ascending limb chloride reabsorption, appear to be mediated by the A 1 receptor the present study the selective A 1 receptor blocker 1,3-dipropyl-8[2-(5,6-epoxy) norbanyl ] xanthine 2, (4) (5) (6) (7) . The current study therefore examined the effect of adenosine A 1 receptor blockade on renal 117) was used to assess the effect of A 1 activation by endogenous adenosine on renal function in rats.
Introduction
loading dose of 25 mg. At the same time, lithium chloride was added to achieve an lithium infusion rate of 0.8 mEq/h Numerous effects of adenosine on renal function have following a loading dose of 0.3 mEq. A PE-10 catheter was been identified by administration of adenosine to inserted in the left ureter for collection of urine. animals and application of adenosine to kidney cells Clearance studies were carried out beginning 120 min after anaesthesia. Baseline measurements were first made [1, 2] . The development of adenosine receptor blockers over a 40-min period. Separate groups of rats then received has made it possible to identify which of these effects bolus infusions of either 0.1 mg/kg or 0.8 mg/kg of CVTare exerted by endogenous adenosine [3] . There are 117 while a third group of time-control rats received only vehicle (200 ml of 1 mM DMSO in saline). After a 10-min 1 blockade in rats 901 determination of haematocrit and plasma inulin, electrolyte, exogenous adenosine and NPIAd are summarized in and protein concentrations. dipropyl-8[2-(5,6-epoxy) norbanyl ] xanthine (CVT-117), which is the most selective A 1 receptor antagonist described to date [8] . Results showed that A 1 blockade
Results
increased sodium excretion and urine flow rate without altering blood pressure. These findings are consistent with those of recent studies which have examined the The effects of A 1 receptor blockade on renal function are summarized in Table 1 . GFR remained stable in rats effects of other A 1 receptor antagonists on renal function in the rat [9, 10] . Similar results were also reported subjected to A 1 receptor blockade and in time control rats which received only vehicle. Both the lower by Kuan et al. [11] using two different, but less potent selective A 1 antagonists. The authors observed an (0.1 mg/kg) and higher (0.8 mg/kg) doses of the A 1 receptor blocker caused marked increases in urine flow increase in urine volume from 6 ml/min to 23 ml/min and an increase in fractional sodium excretion from rate ( V ) and fractional sodium excretion (Fe Na ). In contrast, urine flow and sodium excretion remained 0.3 to 1.69% using the A 1 receptor antagonists DPCPX. In comparison, the higher dose of CVT-117 led to nearly stable in time control rats. Of note, natriuresis and diuresis following selective A 1 receptor blockade in quite similar increases in urine flow from 9 to 25 ml/min and FE Na from 0.5 to 2.0%. The current study, like our study were not associated with increases in the fractional excretion of potassium or phosphorous. An that of Munger and Jackson [10] was carried out in anaesthetized rats which had received plasma to replace insignificant increase in the fractional excretion of lithium was observed in each group of rats, including surgical volume losses. Together with the results of Mizumoto et al. [9] in unanaesthetized rats, these the time controls, while values for haematocrit (Hct) and plasma protein concentration (CA) remained stable. findings suggest that A 1 receptor activation by endogenous adenosine exerts an antinatriuretic effect in the The effects of A 1 receptor blockade on changes in blood pressure and pulse following administration of kidney of volume-replete animals, which is similar to the conclusion of Kuano et al. [11] who found that stimulates phosphate uptake by cultured proximal tubule cells and Na-3HCO 3 cotransport activity in endogenous adenosine with A 1 receptors directly enhances the tubular reabsorption of filtered sodium.
isolated proximal convoluted tubules suggest that exogenous adenosine could promote proximal phosphate A 1 blockade with CVT-117 had no effect on GFR in the current study. Previous studies have suggested and sodium reabsorption [5, 6, 17 ]. In the current study, however, A 1 receptor blockade did not increase fracthat A 1 receptor activation by adenosine is an important mediator of tubuloglomerular feedback [12] . These tional phosphate reabsorption. A 1 receptor blockade did slightly increase the fractional excretion of lithium, results suggest that A 1 blockade could increase the GFR by removing the brake on filtration imposed by but the change observed was not significantly greater than seen in time controls. It should be noted that solute delivery to the macula densa. Balakrishan et al.
[13] recently reported that selective A 1 blockade with adenosine A 1 may alter proximal epithelial transport in part by counteracting the effects of peptide hormones 200 mg of the drug FK453 not only increased sodium excretion and urine flow rates but also significantly such as PTH [1,2,6,18]. The effects of A 1 blockade on proximal phosphate and volume reabsorption which increased GFR 2 h after infusion into normal humans. Notably, the dose of A 1 receptor antagonist required are predicted by in vitro studies might therefore become apparent in vivo under appropriate conditions of to increase the GFR was larger than that required to induce natriuresis. This effect on GFR could not be hormone stimulation.
A 1 blockade increased sodium excretion without observed, however, when patients with chronic renal disease and a mean baseline creatinine clearance of increasing potassium excretion in the current study.
Similar results were obtained in previous studies of A 1 115 ml/min were subjected to exactly the same study [14] . In the current study, however, administration of blockade in rats [9, 10] . These findings suggest that the natriuretic effect of A 1 blockade in volume-replete rats a dose of CVT-117 larger than that required to induce natriuresis and sufficient to block the A 1 effect of a is due, at least in part, to reduction of sodium reabsorption in the distal nephron. Studies in isolated large dose of exogenous adenosine did not increase GFR. This results is in accord with those of previous inner medullary collecting ducts have shown that A 1 receptor activation antagonizes the effect of AVP on studies of A 1 blockade in rats [9, 10] ; however, the influence of anaesthesia as explanation of the different water permeability in this nephron segment [18] .
Enhancement of the effect of AVP could explain why responses of GFR and the differences in phosphate and lithium excretion to selective A 1 blockade in urine flow increased less than sodium excretion during A 1 blockade. The hypothesis that A 1 blockade also human and rat remains to be determined. Another explanation would be that there is a different response decreases sodium reabsorption in the collecting duct remains to be tested in isolated tubule segments. or site of action of A 1 receptor antagonists among species. Yet another alternative explanation would be that the effect of FK 453 on lithium and phosphate Acknowledgements. This work was supported by the Research Service excretion is not mediated via A 1 blockade or that CV-of the Veterans Administration and by CV Therapeutics.
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